Skip to search formSkip to main contentSkip to account menu

Impavido

National Institutes of Health

Related topics

Related topics

3 relations

Broader (1)

miltefosine
miltefosine 50 MG Oral Capsule [Impavido]miltefosine Oral Capsule [Impavido]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2013
2013
Movement ecology of long-distance migrants: insights from the Eleonora's falcon and other raptors
The thesis focused on the study of raptors movements by means of satellite telemetry and is based mainly on the Eleonora's falcon… 
2012
2012
Febrilní pancytopenie a hepatosplenomegalie jako hlavní symptomy viscerální leishmaniózy.
Autoři předkladaji kazuistiku pacienta s febrilni pancytopenii, hepatosplenomegalii a vahovým ubytkem, u ktereho byla složit… 
Highly Cited
2004
Highly Cited
2004
Miltefosine (Impavido): the first oral treatment against leishmaniasis
Miltefosine is a novel antileishmanial drug that has significant selectivity in both in vitro and in vivo models. Clinical… 
2004
2004
[Leishmaniasis--oral treatment with hexadecylphosphocholine].
Hexadecylphosphocholine (HDPC, Miltefosine, Impavido) was synthesized at the Max-Planck-Institut für Biophysikalische Chemie in G… 
1977
1977
[Clinical experience with impavido in treatment of endogenous depressive conditions (author's transl)].
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)